AtriCure, Inc. (ATRC) Guidance & Earnings Results

On 2026-07-23 AtriCure, Inc. raised guidance: "FY2026 revenue ~$602-610M; FY2026 adjusted EBITDA ~$85-89M; FY2026 net income per share $0.05-0.13; FY2026 adjusted EPS $0.24-0.32; continued positive cash…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ATRCAtriCure, Inc.Follow ATRC — free

Medical Instruments & Supplies · Healthcare

—

Price chart with a free account

Market cap: 3.0B
P/E TTM: —
Dividend yield: —
52-week: —
Next earnings: 3 Nov, in 10 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
23 Jul 26	Raised	FY2026 revenue ~$602-610M; FY2026 adjusted EBITDA ~$85-89M; FY2026 net income per share $0.05-0.13; FY2026 adjusted EPS $0.24-0.32; continued positive cash generation · full year
5 May 26	Reaffirmed	Revenue guidance $600-610M, adjusted EBITDA $80-82M · full year
17 Feb 26	Raised	FY2026 revenue guidance $600-610M (+12-14% YoY); adjusted EBITDA $80-82M · full year
12 Jan 26	Raised	2026 revenue guidance $600-610M, up 12-14%
29 Oct 25	Raised	Revenue guidance raised to ~$532-534M from prior; Adjusted EBITDA raised to ~$55-57M · full year
29 Jul 25	Raised	FY2025 revenue raised to ~$527-533M; FY2025 Adjusted EBITDA raised to ~$49-52M; FY2025 adjusted loss per share expected $(0.34)-(0.39); modest cash flow generation expected · full year

AtriCure, Inc. — questions

What guidance did AtriCure, Inc. give?: On 2026-07-23: "FY2026 revenue ~$602-610M; FY2026 adjusted EBITDA ~$85-89M; FY2026 net income per share $0.05-0.13; FY2026 adjusted EPS $0.24-0.32; continued positive cash generation"
When does AtriCure, Inc. report earnings?: AtriCure, Inc.'s next earnings report is expected on 2026-11-03.

Every figure on this page comes from AtriCure, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.